{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:50:05Z","timestamp":1759161005441},"reference-count":32,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union's Seventh Framework Program","award":["280873"],"award-info":[{"award-number":["280873"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.044","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T10:00:51Z","timestamp":1509530451000},"page":"7057-7063","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dissecting antigen processing and presentation routes in dermal vaccination strategies"],"prefix":"10.1016","volume":"35","author":[{"given":"Anouk C.M.","family":"Platteel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Henri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar M.","family":"Zaiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice J.A.M.","family":"Sijts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2017.10.044_b0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2005.04.004","article-title":"Dynamics and function of langerhans cells in vivo: Dermal dendritic cells colonize lymph node areasdistinct from slower migrating langerhans cells","volume":"22","author":"Kissenpfennig","year":"2005","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.044_b0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2005.10.008","article-title":"Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity","volume":"23","author":"Kaplan","year":"2005","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.044_b0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1083\/jcb.200501071","article-title":"Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity","volume":"169","author":"Bennett","year":"2005","journal-title":"J Cell Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.044_b0020","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI59725","article-title":"Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8 + T cells and activating Foxp3 + regulatory T cells","volume":"122","author":"De Ag\u00fcero","year":"2012","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.044_b0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.jbchem.a124327","article-title":"Interferon-\u03b3 induces different subunit organizations and functional diversity of proteasomes","volume":"115","author":"Aki","year":"1994","journal-title":"J Biochem"},{"key":"10.1016\/j.vaccine.2017.10.044_b0030","doi-asserted-by":"crossref","unstructured":"Liepe J, Holzh\u00fctter HG, Bellavista E, Kloetzel PM, Stumpf MPH, Mishto M. Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes. eLife 2015;4:e07545 2015.","DOI":"10.7554\/eLife.07545"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.044_b0035","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1002\/eji.201444902","article-title":"Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation","volume":"44","author":"Mishto","year":"2014","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.044_b0040","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/eji.201545989","article-title":"CD8+ T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products","volume":"46","author":"Platteel","year":"2016","journal-title":"Eur J Immunol"},{"issue":"51","key":"10.1016\/j.vaccine.2017.10.044_b0045","doi-asserted-by":"crossref","first-page":"30417","DOI":"10.1074\/jbc.M115.695189","article-title":"The T210M substitution in the HLA-A*02:01 gp100 epitope strongly affects overall proteasomal cleavage site usage and antigen processing","volume":"290","author":"Textoris-Taube","year":"2015","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.044_b0050","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.4049\/jimmunol.178.12.7557","article-title":"Rates of processing determine the immunogenicity of immunoproteasome- generated epitopes","volume":"178","author":"Deol","year":"2007","journal-title":"Journal of Immunology"},{"issue":"8","key":"10.1016\/j.vaccine.2017.10.044_b0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nm1264","article-title":"A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression","volume":"11","author":"Bins","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.044_b0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ijc.25894","article-title":"Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7","volume":"129","author":"Oosterhuis","year":"2011","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.044_b0065","first-page":"221","article-title":"DNA vaccines and intradermal vaccination by DNA tattooing","volume":"351","author":"Oosterhuis","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.044_b0070","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.4049\/jimmunol.164.9.4500","article-title":"MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells","volume":"164","author":"Sijts","year":"2000","journal-title":"Journal of Immunology"},{"issue":"42","key":"10.1016\/j.vaccine.2017.10.044_b0075","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1016\/j.vaccine.2016.08.039","article-title":"Strategies to enhance immunogenicity of cDNA vaccine encoded antigens by modulation of antigen processing","volume":"34","author":"Platteel","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.044_b0080","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ni852","article-title":"Langerhans cells renew in the skin throughout life under steady-state conditions","volume":"3","author":"Merad","year":"2002","journal-title":"Nat Immunol"},{"issue":"20","key":"10.1016\/j.vaccine.2017.10.044_b0085","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.1073\/pnas.0509307103","article-title":"Langerhans cells cross-present antigen derived from skin","volume":"103","author":"Stoitzner","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.10.044_b0090","doi-asserted-by":"crossref","unstructured":"Mi Q-, Xu Y-, Qi R-, Shi Y-, Zhou L. Lack of microRNA miR-150 reduces the capacity of epidermal langerhans cell cross-presentation. Exp Dermatol 2012;21(11):876-7.","DOI":"10.1111\/exd.12008"},{"issue":"22","key":"10.1016\/j.vaccine.2017.10.044_b0095","doi-asserted-by":"crossref","first-page":"14344","DOI":"10.1073\/pnas.212257299","article-title":"Kloetzel P-, Sijts AJAM. PI31 is a modulator of proteasome formation and antigen processing","volume":"99","author":"Zaiss","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.vaccine.2017.10.044_b0100","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.4049\/jimmunol.154.7.3396","article-title":"An adenovirus type 5 early region 1B-encoded CTL epitope-mediating tumor eradication by CTL clones is down-modulated by an activated ras oncogene","volume":"154","author":"Toes","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.10.044_b0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.coi.2016.04.003","article-title":"Defining cross presentation for a wider audience","volume":"40","author":"Norbury","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.044_b0110","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.4049\/jimmunol.177.9.6018","article-title":"Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells","volume":"177","author":"Dolan","year":"2006","journal-title":"J Immunol"},{"issue":"7340","key":"10.1016\/j.vaccine.2017.10.044_b0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature09863","article-title":"Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection","volume":"471","author":"Wakim","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.044_b0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.imlet.2015.11.002","article-title":"Cross-dressing: an alternative mechanism for antigen presentation","volume":"168","author":"Campana","year":"2015","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.044_b0125","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.4049\/jimmunol.166.6.3645","article-title":"Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner","volume":"166","author":"Hudrisier","year":"2001","journal-title":"J Immunol"},{"issue":"9329","key":"10.1016\/j.vaccine.2017.10.044_b0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.044_b0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2005.08.009","article-title":"Functional connectivity between immune cells mediated by tunneling nanotubules","volume":"23","author":"Watkins","year":"2005","journal-title":"Immunity"},{"issue":"31","key":"10.1016\/j.vaccine.2017.10.044_b0140","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1073\/pnas.1203468109","article-title":"Cross-dressed CD8a+\/CD103+ dendritic cells prime CD8+ T cells following vaccination","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.044_b0145","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.15252\/emmm.201303283","article-title":"Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance","volume":"6","author":"Flacher","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.044_b0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.20091964","article-title":"CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells","volume":"207","author":"Henri","year":"2010","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2017.10.044_b0155","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.1724","article-title":"Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells","volume":"10","author":"Bedoui","year":"2009","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.044_b0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/icb.2010.34","article-title":"Disentangling the complexity of the skin dendritic cell network","volume":"88","author":"Henri","year":"2010","journal-title":"Immunol Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T21:02:44Z","timestamp":1693170164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17314524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17314524"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissecting antigen processing and presentation routes in dermal vaccination strategies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}